By: Dental Review News
As COVID-19 complications are linked to gum disease, LivFresh novel toothpaste eases symptoms
Dental Review reports from the USA: Scientists at UCI’s Beckman Laser Institute & Medical Clinic conduct the first ever study to show that brushing with a novel toothpaste improves symptoms in patients with periodontitis
While several recent studies show that people with chronic gum disease are more likely to experience potentially life-threatening complications if they contract COVID-19, a new study shows promise in addressing the root issue.
Researchers at the University of California Irvine’s Beckman Laser Institute & Medical Clinic recently reported results of a six-month study, published in The Journal of Periodontology, showing for the first time that a novel toothpaste demonstrated medically significant improvements in the health of the gums of patients with periodontitis, the most severe form of gum disease.
Gum disease affects 65 million Americans today (almost half of Americans adults over 30 years of age). New research has shown that COVID-19 patients with gum disease are almost nine times more likely to die compared to those without gum disease.
They were also 3.5 times more likely to be admitted to intensive care, and 4.5 times more likely to need a ventilator. The study found that severe gum disease (periodontitis) is highest among ethnic minorities (63.5% of Hispanic, 59.1% of African American, and 50% of Asian Americans). In other words, severe gum disease could be a contributing factor to a high risk of COVID-related complications and deaths, especially in ethnic communities.
Read the full article on Dental Review News.